Company Quick10K Filing
Genesee & Wyoming
10-Q 2019-09-30 Filed 2019-11-06
10-Q 2019-06-30 Filed 2019-08-07
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-02-26
10-Q 2018-09-30 Filed 2018-11-06
10-Q 2018-06-30 Filed 2018-08-07
10-Q 2018-03-31 Filed 2018-05-07
10-K 2017-12-31 Filed 2018-02-28
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-06-30 Filed 2017-08-07
10-Q 2017-03-31 Filed 2017-05-09
10-K 2016-12-31 Filed 2017-03-01
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-05
10-Q 2016-03-31 Filed 2016-05-05
10-K 2015-12-31 Filed 2016-02-29
10-Q 2015-09-30 Filed 2015-11-06
10-Q 2015-06-30 Filed 2015-08-07
10-Q 2015-03-31 Filed 2015-05-07
10-K 2014-12-31 Filed 2015-02-27
10-Q 2014-09-30 Filed 2014-11-04
10-Q 2014-06-30 Filed 2014-08-06
10-Q 2014-03-31 Filed 2014-05-09
10-K 2013-12-31 Filed 2014-02-27
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-06
10-Q 2013-03-31 Filed 2013-05-09
10-K 2012-12-31 Filed 2013-03-01
10-Q 2012-09-30 Filed 2012-11-09
10-Q 2012-06-30 Filed 2012-08-07
10-Q 2012-03-31 Filed 2012-05-07
10-K 2011-12-31 Filed 2012-02-27
10-Q 2011-09-30 Filed 2011-11-04
10-Q 2011-06-30 Filed 2011-08-05
10-Q 2011-03-31 Filed 2011-05-06
10-K 2010-12-31 Filed 2011-02-25
10-Q 2010-09-30 Filed 2010-11-08
10-Q 2010-06-30 Filed 2010-08-06
10-Q 2010-03-31 Filed 2010-05-05
10-K 2009-12-31 Filed 2010-02-26
8-K 2019-10-24
8-K 2019-10-03
8-K 2019-09-25
8-K 2019-09-17
8-K 2019-08-04
8-K 2019-06-30
8-K 2019-05-22
8-K 2019-04-30
8-K 2019-02-08
8-K 2019-02-06
8-K 2018-11-02
8-K 2018-10-30
8-K 2018-10-17
8-K 2018-07-27
8-K 2018-06-05
8-K 2018-05-23
8-K 2018-05-01
8-K 2018-04-03
8-K 2018-02-08
8-K 2018-01-16

Genesee & Wyoming Financials

GWR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
Ameren Illinois Co (AILNP)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
Bioquest Corp (BQST)
30DC (TDCH)
BriaCell Therapeutics Corp. (BCTXW)
DD3 Acquisition Corp. II (DDMXW)
3D Total Solutions (DTLS)
3DX Industries (DDDX)
8i Acquisition 2 Corp. (LAX)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash159197272726162729505166529193263323319601123039363925263238848080121707490708287
Accounts Receivable102114132141153145166163160173263264309313325326352349357394386359382362369366364355380416417423436441426440444437
Inventory
PP&E1,0151,0521,4441,4481,5031,5622,0081,6801,7131,7693,8413,4003,3603,4253,9933,4623,7783,7754,4624,0154,1044,0865,0124,2314,2094,2105,4804,5314,5914,6295,8634,6414,6144,6135,9854,6444,6704,665
Assets1,7301,8192,0682,0822,1462,1882,2942,3332,3822,9215,2265,1935,2105,2735,3205,2875,6105,5665,5966,7586,8066,7176,7966,7066,6206,6167,6357,7117,9368,0298,0358,0717,9207,9047,8688,3828,3648,284
Accounts Payable104117125121132140134122112140232216212221242206249266291318318294282257238246267255255255254252272272288283270278
Long-Term Debt4084024754765705976765785645941,8581,8061,7381,6671,6251,5801,7631,6431,6552,4102,3422,2512,3402,1422,0691,9782,4272,3062,3982,3542,3932,3422,3572,3012,5162,3922,2812,177
Liabilities1,0091,0501,3451,4673,7313,2083,1893,1703,1723,0943,3433,2623,2394,7404,7624,9064,9134,4564,3904,3624,3434,4474,9334,8774,776
Stockholders' Equity7217691,0371,4541,4951,9852,0212,1032,1482,1932,2672,3032,3572,8952,9483,0303,1163,5793,6813,5593,5613,4223,4493,4883,509
Income Statement ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue158156170192210217210207217223227375553401392376415433416397542546515483501501517519540577572575595603576558571584
Cost of Revenue
Gross Profit
R&D
SG&A
Tax1212-48111212181525222423333715172937-713222020223031-343-162631141920
Net Income212520223133332236-20138313966584061738824536385274857927485342776497256395170
Cash Flow ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating54457457448286379163891261357212816912284101160131788414210385139126129101130166103120161
Cash Investing-21-361-8-39-126-63-41-40-51-1,969-32-72-39-57-306-77-70-790-90-106-88-37-41-39-1,018-25-151-57-74-49-61-55-59-23-71
Cash Financing-51442614-14381,512-67-29-73-45179-107-12762-95-37-49-39-57-102918-5656-75-55-11-121-106-66-87-84